Author:
Khoury Lana,Shwartz Naddam Irit,Paz Tzruia Meital,Shehadeh Shereen,Konopnicki Muriel,Hamad Saied Mohamad,Meiri Noam,Livnat Galit,Yaacoby-Bianu Karin
Publisher
Springer Science and Business Media LLC
Reference33 articles.
1. Madhi, S. A. et al. The burden of childhood pneumonia in the developed world. Pediatr. Infect. Dis. J. 32 (3), 1 (2012).
2. Bradley, J. S. et al. The management of Community-Acquired pneumonia in infants and children older than 3 months of age: clinical practice guidelines by the pediatric infectious diseases society and the infectious diseases society of America. Clin. Infect. Dis. 53 (7), e25–76 (2011).
3. Paladino, J. A., Adelman, M. H., Schentag, J. J. & Iannini, P. B. Direct costs in patients hospitalised with community-acquired pneumonia after non-response to outpatient treatment with macrolide antibacterials in the US. Pharmacoeconomics 25 (8), 677–683 (2007).
4. Zhang, S. et al. Cost of management of severe pneumonia in young children: systematic analysis. J. Glob Health ;6(1). (2016).
5. Sauteur, P. M. M. Childhood community-acquired pneumonia. Eur. J. Pediatr. 183, 1129–1136 (2024).